Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$4,082,859
+$338,334 QoQ
Shares Held
16,225
-5.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#1,441
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Plancorp, LLC holds $29,476,537 across 10 Drug Manufacturers - General names. ABBV ranks #2 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,332 | $13,591,941 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
16,225 | $4,082,859 | |
| 3 | JNJ |
Johnson & Johnson
|
14,300 | $3,631,771 | |
| 4 | NVS |
Novartis AG
|
12,291 | $1,926,245 | |
| 5 | PFE |
Pfizer Inc
|
69,231 | $1,667,082 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,133 | $1,559,090 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,457 | $948,252 | |
| 8 | AMGN |
Amgen Inc
|
2,399 | $868,725 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,082,859 | 16,225 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $3,744,525 | 17,217 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $3,930,941 | 17,204 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,994,528 | 17,252 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $3,360,650 | 18,105 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $3,722,122 | 17,765 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,941,823 | 16,555 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,022,431 | 15,305 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,649,297 | 15,446 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,903,038 | 15,942 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,372,900 | 15,312 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,241,713 | 15,039 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,930,815 | 14,331 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $2,244,407 | 14,083 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,276,276 | 14,085 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,900,279 | 14,159 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,193,404 | 14,321 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,263,217 | 13,961 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,800,278 | 13,296 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,406,624 | 13,040 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,475,696 | 13,101 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,426,556 | 13,182 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,462,276 | 13,647 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,134,290 | 12,950 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,375,796 | 14,013 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $902,241 | 11,842 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||